Literature DB >> 12001129

Malignant placental site trophoblastic tumor: a cytogenetic study using comparative genomic hybridization and chromosome in situ hybridization.

Wei-Cheng Xue1, Xin-Yuan Guan, Hextan Y S Ngan, Dan-Hua Shen, Ui-Soon Khoo, Annie N Y Cheung.   

Abstract

BACKGROUND: Placental site trophoblastic tumor (PSTT) is a rare form of gestational trophoblastic neoplasm composed predominantly of intermediate trophoblast. Most showed benign behavior whereas 10-15% of PSTTs were clinically malignant with later recurrence and metastasis. Currently, there are no reliable means to predict clinical outcome, and cytogenetic information is scanty.
METHODS: The clinicopathologic features of two cases of malignant PSTT were analyzed. Cytogenetic analysis was performed by comparative genomic hybridization (CGH) and chromosome in situ hybridization (CISH) using frozen tissue and paraffin embedded sections, respectively.
RESULTS: Both patients were 32 years old at time of diagnosis. One patient with PSTT presented with menorrhagia, and the other presented with symptoms of missed abortion. Elevated serum human chorionic gonadotropin (HCG) was detected in both patients. Histologic examination showed the typical features of PSTT with high mitotic count (> 5/10 high-power fields). Ovarian and lung metastasis occurred in both patients. Immunohistochemical staining revealed an equal distribution of HCG and human placental lactogen. Cytogenetic studies by CISH showed that karyotypes of these two malignant PSTTs were diploid. Analysis of the tumor tissue by CGH did not show any changes in DNA copy numbers.
CONCLUSIONS: The authors' study indicated that the two metastasizing PSTTs had balanced diploid karyotype. The malignant behavior of PSTTs may be not related to the DNA copy number changes. Such cytogenetic study may be useful in distinguishing metastatic PSTT from choriocarcinoma. Copyright 2002 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12001129     DOI: 10.1002/cncr.10424

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Chromosome in situ hybridisation, Ki-67, and telomerase immunocytochemistry in liquid based cervical cytology.

Authors:  A N Y Cheung; P M Chiu; K L Tsun; U S Khoo; B S Y Leung; H Y S Ngan
Journal:  J Clin Pathol       Date:  2004-07       Impact factor: 3.411

Review 2.  Placental site trophoblastic tumor.

Authors:  Nadereh Behtash; Mojgan Karimi Zarchi
Journal:  J Cancer Res Clin Oncol       Date:  2007-08-16       Impact factor: 4.553

3.  LPCAT1-TERT fusions are uniquely recurrent in epithelioid trophoblastic tumors and positively regulate cell growth.

Authors:  Gavin R Oliver; Sofia Marcano-Bonilla; Jonathan Quist; Ezequiel J Tolosa; Eriko Iguchi; Amy A Swanson; Nicole L Hoppman; Tanya Schwab; Ashley Sigafoos; Naresh Prodduturi; Jesse S Voss; Shannon M Knight; Jin Zhang; Numrah Fadra; Raul Urrutia; Michael Zimmerman; Jan B Egan; Anthony G Bilyeu; Jin Jen; Ema Veras; Rema'a Al-Safi; Matthew Block; Sarah Kerr; Martin E Fernandez-Zapico; John K Schoolmeester; Eric W Klee
Journal:  PLoS One       Date:  2021-05-25       Impact factor: 3.240

Review 4.  A Review on the Pathogenesis and Clinical Management of Placental Site Trophoblastic Tumors.

Authors:  Xuan Feng; Zhi Wei; Sai Zhang; Yan Du; Hongbo Zhao
Journal:  Front Oncol       Date:  2019-11-28       Impact factor: 6.244

5.  Imaging and Clinical Data of Placental Site Trophoblastic Tumor: A Case Report.

Authors:  Maryam Niknejadi; Firoozeh Ahmadi; Farnaz Akhbari
Journal:  Iran J Radiol       Date:  2016-04-16       Impact factor: 0.212

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.